QL
CYTK icon

Quarry LP’s Cytokinetics CYTK Stock Holding History

Quarry LP’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Buy
+4,058
New +$291K 0.03% 222
2026
Q1 		– Sell
-147
Closed -$9.34K – 1621
2025
Q4 		$9.34K Sell
147
-402
-73% -$25K ﹤0.01% 1438
2025
Q3 		$30.2K Buy
+549
New +$22.6K 0.01% 1153
2025
Q1 		– Sell
-800
Closed -$37.6K – 1706
2024
Q4 		$37.6K Sell
800
-2,200
-73% -$114K 0.01% 903
2024
Q3 		$158K Buy
3,000
+1,000
+50% +$55.7K 0.04% 294
2024
Q2 		$108K Buy
2,000
+1,400
+233% +$84.5K 0.03% 315
2024
Q1 		$42.1K Buy
+600
New +$46.4K 0.01% 543

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's CYTK Position: Q2 2026 in Review

Quarry LP opened a new position in Cytokinetics (CYTK) in Q2 2026: 4,058 shares worth $346K. The stake represents 0.03% of the portfolio and ranks #222 among its holdings. This is a return to the name: Quarry LP previously reported a position in CYTK as recently as Q4 2025.

Quarry LP first reported a position in CYTK in Q1 2024 and has held it in 7 quarters since. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Quarry LP held 4,058 shares of Cytokinetics worth $346K as of Q2 2026.
  • Cytokinetics was a new Quarry LP position in Q2 2026.
  • Cytokinetics made up 0.03% of Quarry LP's portfolio in Q2 2026, its #222 holding.
  • Quarry LP first reported a position in Cytokinetics in Q1 2024 and has held it in 7 quarters since.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.